Share Issue News

Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.

Apr 25, 2025 at 5:00 PM

Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on March 5, 2025, the Compensation Committee of Energy Vault’s Board of Directors granted to 12 new, non-executive employees, restricted stock unit awards covering 637,600 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”)....
Apr 25, 2025 at 4:05 PM

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For...
Apr 25, 2025 at 4:05 PM

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and...
Apr 24, 2025 at 4:35 PM

Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 39,750 shares of the Company’s common stock at an exercise price per share of $8.11, which was the closing price on April 23, 2025 and re...
Apr 24, 2025 at 7:01 AM

Ameriprise Financial Announces Additional $4.5 Billion Share Repurchase Authorization; Increases Regular Quarterly Dividend 8 Percent to $1.60 per share

MINNEAPOLIS--(BUSINESS WIRE)--The Board of Directors of Ameriprise Financial, Inc. (NYSE: AMP) has announced the following: The company authorized an additional $4.5 billion for the repurchase of shares of its common stock during the period of April 24, 2025 through the close of business on June 30, 2027. As of April 23, 2025, the company had approximately $138 million available from its July 2023 authorization, which is available through September 30, 2025. The company intends to fund share re...
Apr 24, 2025 at 1:35 AM

Innate Pharma Announces €15M Investment by Sanofi

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announces a €14,999,998.59 capital increase subscribed by Sanofi. As announced on April 23, 2025, and given the satisfactory market conditions, Sanofi has agreed to subscribe to 8,345,387 new ordinary shares of Innate, at a price of €1.7974 per share, representing a total capital increase of €14,999,998.59 (€417,269.35 in nominal amount and €14,582,729.24 o...
Apr 23, 2025 at 4:32 PM

Community Health Systems, Inc. Announces Commencement of Cash Tender Offer for 6.875% Senior Unsecured Notes Due 2028

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has commenced a cash tender offer (the “Tender Offer”) for any and all of its outstanding 6.875% Senior Unsecured Notes due 2028 (the “Notes”) on the terms and subject to the conditions set forth in the Issuer’s Offer to Purchase and Consent Solicitation Statement, dated April 23, 2025 (the “Offer to Pur...
Apr 22, 2025 at 4:41 PM

Veritone Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DENVER--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered enterprise AI solutions, today announced that the Compensation Committee of its Board of Directors granted an equity award on April 2, 2025 under its Inducement Grant Plan to one new employee, as an inducement material to her entering into employment with Veritone in accordance with Nasdaq Listing Rule 5635(c)(4). This equity award consists of restricted stock units representing the right to receive upon...
Apr 22, 2025 at 11:45 AM

Eurofins: Purchases of Own Shares From April 14th to April 17th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 14/03/2025 FR0014000MR3 102,000 49.4276 XPAR EUROFINS 529900JEHFM47DYY3S57 14/03/2025 FR0014000MR3 40,000 49.5281 CEUX EUROFINS 529900JEHFM47DYY3S57 14/03/2025 FR0014000MR3 4,000...
Apr 22, 2025 at 8:00 AM

Eagle Point Credit Company Inc. Increases Offering Amount of 7.00% Convertible Perpetual Preferred Stock to $200 Million

GREENWICH, Conn.--(BUSINESS WIRE)--Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC) announced it has increased the continuous public offering of its 7.00% Series AA Convertible Perpetual Preferred Stock and 7.00% Series AB Convertible Perpetual Preferred Stock (collectively, the “Preferred Stock”) to up to 8,000,000 shares at a public offering price of $25 per share, for gross proceeds to the Company of $200 million. The Preferred Stock has a 7.00% annual dividend rate, paid monthly,...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up